Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for Sarcoidosis Associated Pulmonary Hypertension
NCT00851929Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambrisentan in pulmonary hypertension (PH), sponsored by Medical University of South Carolina. Started Nov 2008; status: completed.
02
Drugs
ambrisentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00851929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851929.